Global Atrial Fibrillation Market was valued at USD 15445 Million in the year 2020 and is expected to grow at USD 43653 Million till 2027 recording a CAGR of 16% for the forecast period 2021-2027. Atrial Fibrillation Market is a type of heart arrhythmia, which is caused by unpredictable electrical exercises in the atria. The main characteristics include, palpitations, congestive disappointment of the heart or chest torment. The affirmation for AF is acquired by an electrocardiogram which shows a nonattendance of the P wave and unpredictable rate of ventricular constrictions. These anomalies in the consistent cardio-electric motivations of the sino-atrial hub are the after effect of impedance from riotous electric driving forces creating from foundations of pneumonic veins prompting conduction of an unpredictable pulse. Atrial fibrillation based on the seriousness of the condition is partitioned into three sorts to be specific paroxysmal (side effects stop inside 24 hours), determined (side effects proceed for over seven days) and perpetual (long haul) atrial fibrillation. The rising prevalence of strokes, brain damage, and atrial fibrillation due to blood clots, as well as an increasing senior population, are driving the atrial fibrillation market. The market is predicted to expand due to technological developments in microwave catheter ablation and radiofrequency ablation, as well as the rising occurrence of disorders induced by lifestyle factors such as drinking and smoking.